Guardant Health (GH) EBIT: 2017-2025
Historic EBIT for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$99.0 million.
- Guardant Health's EBIT rose 15.63% to -$99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$442.4 million, marking a year-over-year increase of 14.12%. This contributed to the annual value of -$443.6 million for FY2024, which is 21.45% up from last year.
- Latest data reveals that Guardant Health reported EBIT of -$99.0 million as of Q3 2025, which was up 6.98% from -$106.4 million recorded in Q2 2025.
- In the past 5 years, Guardant Health's EBIT ranged from a high of -$97.6 million in Q2 2021 and a low of -$197.5 million during Q4 2023.
- Over the past 3 years, Guardant Health's median EBIT value was -$113.5 million (recorded in 2023), while the average stood at -$120.4 million.
- Its EBIT has fluctuated over the past 5 years, first crashed by 208.96% in 2021, then soared by 36.22% in 2024.
- Quarterly analysis of 5 years shows Guardant Health's EBIT stood at -$98.2 million in 2021, then slumped by 48.79% to -$146.1 million in 2022, then tumbled by 35.17% to -$197.5 million in 2023, then skyrocketed by 36.22% to -$126.0 million in 2024, then increased by 15.63% to -$99.0 million in 2025.
- Its last three reported values are -$99.0 million in Q3 2025, -$106.4 million for Q2 2025, and -$111.0 million during Q1 2025.